SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
24-Aug-23 12:14 PM View: | Nrx Pharmaceuticals, Inc. (NRXP) | 23-Aug-23 | Private Purchase | 100,000 | $0.33 | $33,000.00 | < 1% 14.67M to 14.77M | |
23-Aug-23 9:24 AM View: | Nrx Pharmaceuticals, Inc. (NRXP) | 22-Aug-23 | Private Purchase | 200,000 | $0.32 | $64,400.00 | 1% 14.47M to 14.67M | |
14-Feb-23 10:00 PM View: | Nrx Pharmaceuticals, Inc. (NRXP) | 14-Dec-22 | Gift | 300,000 | -- | -- | (2%) 14.77M to 14.47M | |
09-Dec-22 4:33 PM View: | Nrx Pharmaceuticals, Inc. (NRXP) | 07-Dec-22 | Sale | 400,000 | $1.00 | $400,000.00 | (3%) 14.87M to 14.47M | |
02-Jun-22 8:55 AM View: | Nrx Pharmaceuticals, Inc. (NRXP) | 01-Jun-22 | Purchase | 100,000 | $58.00 | $5,800,000.00 | < 1% 14.77M to 14.87M | |
10-Jun-21 6:48 PM View: | Nrx Pharmaceuticals, Inc. (NRXP) | 24-May-21 | Grant | 46,332 | -- | -- | 100% 0 to 46.33K | |
10-Jun-21 6:48 PM View: | Nrx Pharmaceuticals, Inc. (NRXP) | 24-May-21 | Grant | 14,771,000 | -- | -- | 31881% 46.3K to 14.82M | |
16-Feb-10 5:29 PM View: | Brainstorm Cell Therapeutic... (BCLI) | 22-Oct-09 | Market Sale | 31,610 | $0.32 | $10,115.20 | (6%) 491.61K to 460.0K | 74% |
16-Feb-10 5:29 PM View: | Brainstorm Cell Therapeutic... (BCLI) | 14-Oct-09 | Market Sale | 60,000 | $0.32 | $19,200.00 | (11%) 551.61K to 491.61K | 74% |
16-Feb-10 5:29 PM View: | Brainstorm Cell Therapeutic... (BCLI) | 06-Oct-09 | Market Sale | 48,869 | $0.34 | $16,371.10 | (8%) 600.48K to 551.61K | 75% |
16-Feb-10 5:29 PM View: | Brainstorm Cell Therapeutic... (BCLI) | 05-Oct-09 | Market Sale | 87,509 | $0.34 | $29,324.30 | (13%) 687.99K to 600.48K | 75% |
16-Feb-10 5:29 PM View: | Brainstorm Cell Therapeutic... (BCLI) | 02-Oct-09 | Market Sale | 5,224 | $0.34 | $1,750.04 | (< 1%) 693.21K to 687.99K | 75% |
16-Feb-10 5:29 PM View: | Brainstorm Cell Therapeutic... (BCLI) | 01-Oct-09 | Market Sale | 2,800 | $0.34 | $952.00 | (< 1%) 696.01K to 693.21K | 75% |
16-Feb-10 5:29 PM View: | Brainstorm Cell Therapeutic... (BCLI) | 30-Sep-09 | Market Sale | 50,000 | $0.32 | $15,760.00 | (7%) 746.01K to 696.01K | 74% |
16-Feb-10 5:29 PM View: | Brainstorm Cell Therapeutic... (BCLI) | 29-Sep-09 | Market Sale | 213,988 | $0.34 | $71,985.60 | (22%) 960.0K to 746.01K | 75% |
28-Aug-08 4:58 PM View: | Brainstorm Cell Therapeutic... (BCLI) | 27-Aug-08 | Market Sale | 40,000 | $0.25 | $10,000.00 | (4%) 1000.0K to 960.0K | (12%) |
28-Aug-08 4:58 PM View: | Brainstorm Cell Therapeutic... (BCLI) | 27-Aug-08 | Exercise (in-the money or at-the-money) | 1,000,000 | $0.01 | $10,000.00 | 100% 0 to 1000.0K | 2700% |
16-Feb-10 5:29 PM View: | Brainstorm Cell Therapeutic... (BCLI) | 03-Aug-08 | Purchase | 960,000 | $275,000.00 | $263,999,995,904.00 | 100% 0 to 960.0K | |
05-Jul-05 7:28 PM View: | Quality Systems Inc. (NXGN) | 17-Jun-05 | Option Exercise | 4,000 | $49.05 | $196,190.00 | 98% 4.07K to 8.07K | 96% |